Stay updated on Efficacy of Liraglutide in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Liraglutide in Type 2 Diabetes Clinical Trial page.

Latest updates to the Efficacy of Liraglutide in Type 2 Diabetes Clinical Trial page
- CheckyesterdayChange DetectedThe page now includes a Locations section with Barcelona and Navarre, replacing the previous location blocks; the revision is updated to v3.3.3.SummaryDifference0.3%

- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedThe Publications section text was updated to indicate that publications are automatically filled from PubMed and may not all pertain to the study. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check37 days agoChange DetectedA site-wide government funding status notice that previously appeared on the page was removed, with no impact on study details or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check51 days agoChange DetectedThe screenshots show only minor cosmetic edits to the Study Details page (wording and layout) with no changes to core study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check80 days agoChange DetectedAdded a government-operating-status notice and a new version tag (v3.2.0); removed the old version tag (v3.1.0).SummaryDifference3%

- Check87 days agoChange DetectedUpdated to Revision: v3.1.0 and removed several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) while keeping the revision label as the primary addition.SummaryDifference0.3%

Stay in the know with updates to Efficacy of Liraglutide in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Liraglutide in Type 2 Diabetes Clinical Trial page.